BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 27801556)

  • 1. Progress towards eliminating onchocerciasis in the WHO Region of the Americas: verification of elimination of transmission in Guatemala.
    Wkly Epidemiol Rec; 2016 Oct; 91(43):501-5. PubMed ID: 27801556
    [No Abstract]   [Full Text] [Related]  

  • 2. The Onchocerciasis Elimination Program for the Americas (OEPA).
    Sauerbrey M
    Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():25-9. PubMed ID: 18718151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress towards eliminating onchocerciasis in the WHO Region of the Americas in 2011: interruption of transmission in Guatemala and Mexico.
    Wkly Epidemiol Rec; 2012 Aug; 87(33):309-14. PubMed ID: 22905372
    [No Abstract]   [Full Text] [Related]  

  • 4. The positive influence the Onchocerciasis Elimination Program for the Americas has had on Africa programs.
    Richards FO; Nwoke BEB; Zarroug I; Tukahebwa E; Negussu N; Higazi TB; Oguttu D; Tadesse Z; Miri E; Aziz N; Habomugisha P; Katabarwa M
    Infect Dis Poverty; 2019 Jul; 8(1):52. PubMed ID: 31303175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress towards eliminating onchocerciasis in the WHO Region of the Americas: elimination of transmission in the north-east focus of the Bolivarian Republic of Venezuela.
    Wkly Epidemiol Rec; 2017 Oct; 92(41):617-23. PubMed ID: 29028167
    [No Abstract]   [Full Text] [Related]  

  • 6. One Hundred Years After Its Discovery in Guatemala by Rodolfo Robles, Onchocerca volvulus Transmission Has Been Eliminated from the Central Endemic Zone.
    Richards F; Rizzo N; Diaz Espinoza CE; Monroy ZM; Crovella Valdez CG; de Cabrera RM; de Leon O; Zea-Flores G; Sauerbrey M; Morales AL; Rios D; Unnasch TR; Hassan HK; Klein R; Eberhard M; Cupp E; Domínguez A
    Am J Trop Med Hyg; 2015 Dec; 93(6):1295-304. PubMed ID: 26503275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan(®)) monotherapy.
    Cupp EW; Sauerbrey M; Richards F
    Acta Trop; 2011 Sep; 120 Suppl 1():S100-8. PubMed ID: 20801094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of onchocerciasis in Africa by 2025: the need for a broad perspective.
    Cupp E; Sauerbrey M; Cama V; Eberhard M; Lammie PJ; Unnasch TR
    Infect Dis Poverty; 2019 Jul; 8(1):50. PubMed ID: 31303176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report from the 2009 Inter-American Conference on Onchocerciasis: progress towards eliminating river blindness in the Region of the Americas.
    Wkly Epidemiol Rec; 2010 Aug; 85(33):321-6. PubMed ID: 20707042
    [No Abstract]   [Full Text] [Related]  

  • 10. Onchocerciasis (river blindness). Report from the fifteenth InterAmerican Conference on Onchocerciasis, Caracas, Venezuela.
    Wkly Epidemiol Rec; 2006 Jul; 81(30):293-6. PubMed ID: 16874924
    [No Abstract]   [Full Text] [Related]  

  • 11. Short report: impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year.
    Cupp EW; Cupp MS
    Am J Trop Med Hyg; 2005 Dec; 73(6):1159-61. PubMed ID: 16354830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new key-player for onchocerciasis elimination.
    Jesudason T
    Lancet Infect Dis; 2023 Apr; 23(4):413. PubMed ID: 36965498
    [No Abstract]   [Full Text] [Related]  

  • 13. The need for evidence-based strategies and tools for onchocerciasis elimination in Africa.
    Dadzie Y; Amazigo UV; Boatin BA; Sékétéli A
    Infect Dis Poverty; 2019 Jul; 8(1):62. PubMed ID: 31303174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of onchocerciasis today: status and challenges.
    Richards FO; Boatin B; Sauerbrey M; Sékétéli A
    Trends Parasitol; 2001 Dec; 17(12):558-63. PubMed ID: 11756018
    [No Abstract]   [Full Text] [Related]  

  • 15. Seventeen years of annual distribution of ivermectin has not interrupted onchocerciasis transmission in North Region, Cameroon.
    Katabarwa MN; Eyamba A; Nwane P; Enyong P; Yaya S; Baldiagaï J; Madi TK; Yougouda A; Andze GO; Richards FO
    Am J Trop Med Hyg; 2011 Dec; 85(6):1041-9. PubMed ID: 22144441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of onchocerciasis in the WHO Region of the Americas: Ecuador’s progress towards verification of elimination.
    Wkly Epidemiol Rec; 2014 Sep; 89(37):401-5. PubMed ID: 25221799
    [No Abstract]   [Full Text] [Related]  

  • 17. Rapid suppression of Onchocerca volvulus transmission in two communities of the Southern Chiapas focus, Mexico, achieved by quarterly treatments with Mectizan.
    Rodríguez-Pérez MA; Lutzow-Steiner MA; Segura-Cabrera A; Lizarazo-Ortega C; Domínguez-Vázquez A; Sauerbrey M; Richards F; Unnasch TR; Hassan HK; Hernández-Hernández R
    Am J Trop Med Hyg; 2008 Aug; 79(2):239-44. PubMed ID: 18689630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination of onchocerciasis from Colombia: first proof of concept of river blindness elimination in the world.
    Nicholls RS; Duque S; Olaya LA; López MC; Sánchez SB; Morales AL; Palma GI
    Parasit Vectors; 2018 Apr; 11(1):237. PubMed ID: 29642939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress toward eliminating onchocerciasis in the WHO Region of the Americas: verification of elimination of transmission in Mexico.
    Wkly Epidemiol Rec; 2015 Oct; 90(43):577-81. PubMed ID: 26495516
    [No Abstract]   [Full Text] [Related]  

  • 20. The burden of Onchocerca volvulus in Sudan.
    Mukhtar MM; Khier MM; Baraka OZ; Homeida MM
    Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S129-31. PubMed ID: 9861278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.